Search

everythinglearnresearchcommunity

for

Search:↓

Individualized treatment improves symptoms and quality of life for women with PCOS.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Androgens affect the function and health of the endometrium.

PCOS is linked to low-grade chronic inflammation.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Skin issues are common and important for diagnosing PCOS.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.